H.U. Group Holdings, Inc. (MRCHF)
OTCMKTS · Delayed Price · Currency is USD
19.88
0.00 (0.00%)
At close: Jan 30, 2026
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 62.34B JPY in the quarter ending December 31, 2025, with 0.45% growth. This brings the company's revenue in the last twelve months to 247.71B, up 2.58% year-over-year. In the fiscal year ending March 31, 2025, H.U. Group Holdings had annual revenue of 243.03B with 2.56% growth.
Revenue (ttm)
247.71B JPY
Revenue Growth
+2.58%
P/S Ratio
0.73
Revenue / Employee
45.50M JPY
Employees
5,444
Market Cap
1.16B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Interpace Biosciences | 41.92M |
| Psychemedics | 19.69M |
| China New Energy Group Company | 12.51M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 4.15M |